Author: Park, Wan Beom; Jun, Kang Il; Kim, Gayeon; Choi, Jae-Phil; Rhee, Ji-Young; Cheon, Shinhyea; Lee, Chang Hyun; Park, Jun-Sun; Kim, Yeonjae; Joh, Joon-Sung; Chin, Bum Sik; Choe, Pyeong Gyun; Bang, Ji Hwan; Park, Sang-Won; Kim, Nam Joong; Lim, Dong-Gyun; Kim, Yeon-Sook; Oh, Myoung-don; Shin, Hyoung-Shik
Title: Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome Document date: 2018_5_10
ID: 702d5pvf_4
Snippet: CT was performed 1 year after MERS-CoV infection in 65 (89%) patients. Radiological sequelae were revealed in 25% (4/16), 63% (19/30), and 95% (18/19) of patients in the no, mild, and severe pneumonia groups, respectively (P < 0.001). The median radiological sequelae score was 0, 1, and 3 in the no, mild, and severe pneumonia groups, respectively, and the radiological sequelae scores were significantly correlated with the severity of pneumonia (P.....
Document: CT was performed 1 year after MERS-CoV infection in 65 (89%) patients. Radiological sequelae were revealed in 25% (4/16), 63% (19/30), and 95% (18/19) of patients in the no, mild, and severe pneumonia groups, respectively (P < 0.001). The median radiological sequelae score was 0, 1, and 3 in the no, mild, and severe pneumonia groups, respectively, and the radiological sequelae scores were significantly correlated with the severity of pneumonia (P < 0.001, This is the first cohort study showing long-term pulmonary complications of MERS-CoV infection. The findings suggest that more severe MERS pneumonia can result in more impaired lung function at least 1 year after MERS-CoV infection. These findings were compatible with radiological sequelae.
Search related documents:
Co phrase search for related documents- cohort study and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- cohort study and MERS cov infection: 1, 2, 3, 4, 5, 6, 7, 8
- cohort study and pneumonia group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and pneumonia severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and pulmonary complication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cohort study and severe mild pneumonia group: 1
- long term and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- long term and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- long term and MERS cov infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
- long term and pneumonia group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- long term and pneumonia severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- long term and pulmonary complication: 1, 2, 3, 4, 5, 6, 7, 8
- long term and sequelae score: 1
- long term and severe mild pneumonia group: 1
- lung function and pneumonia group: 1, 2, 3, 4
- lung function and pneumonia severity: 1, 2, 3, 4, 5, 6, 7
- lung function and pulmonary complication: 1, 2, 3, 4, 5, 6, 7
- lung function and sequelae score: 1
Co phrase search for related documents, hyperlinks ordered by date